ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1474

Early Peak of Cardiovascular Events Occurs Equally in Caucasians and African-American SLE but Is Attributed to Different Risk Factors

Michelle Petri1, Jessica Li2 and Daniel Goldman1, 1Johns Hopkins University School of Medicine, Timonium, MD, 2Johns Hopkins University, Baltimore, MD

Meeting: ACR Convergence 2020

Keywords: Cardiovascular, race/ethnicity, risk factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: Epidemiology & Public Health III: Risk Factors & Outcomes (1472–1476)

Session Type: Abstract Session

Session Time: 5:00PM-5:50PM

Background/Purpose: The classic bimodal pattern of morbidity/mortality in SLE highlighted that cardiovascular events occurred later in the natural history of SLE (Urowitz & Gladman. J Rheumatol 1980;7:412-16).  This paradigm has now been challenged by the SLICC international inception cohort that found cardiovascular events early in the disease course (Urowitz et al. Lupus Sci Med 3:e000143, 2016). Furthermore, in the Georgia Lupus Registry, cardiovascular deaths peaked 1-2 years after diagnosis, with African-American ethnicity as the strongest predictor.  We examined the timing of cardiovascular events in a different U.S. cohort, balanced for Caucasian and African-American ethnicities.

Methods: SLE was defined by the revised ACR or SLICC classification criteria.  Cardiovascular events were defined as myocardial infarction (MI) or stroke (ACC/AHA definition).  In our cohort of 2,398 patients, 1,029 were African-American and 1,369 Caucasian.  Nineteen were missing a SLE diagnosis date and 9 had missing data on events.  There were 230 strokes and 116 myocardial infarctions.

Results: Figure 1A (African-American) and Figure 1B (Caucasian) show the number of cardiovascular events by ethnicity.  The peak was years 0-2 after diagnosis for both ethnicities.  Figure 2 is a Kaplan-Meier showing stroke probability by year after SLE diagnosis, with no difference found between African-American and Caucasian SLE. Similarly, there was no difference for MI. Table 1 shows that African-American and Caucasian SLE patients differed significantly in their risk factors for MI or for stroke. For example, hypertension was a significant risk factor in Caucasians for MI, while lupus anticoagulant was a significant risk factor in Caucasians for stroke.

Conclusion: In agreement with recent studies, we found an early peak of cardiovascular events (MI and stroke).  Contrary to the Georgia Lupus Registry, we saw no difference for MI or storke in Caucasian vs. African-American patients by year after diagnosis.  Instead, we found important differences in risk factors for stroke and MI in African-American vs Caucasian SLE patients.

Cardiovascular events (CVA and MI) by year after SLE diagnosis among African-American patients (A) and among Caucasian Patients (B)

Estimated Probability of Remaining Stroke Free for Caucasians and African Americans, by Year After SLE Diagnosis

Associations Between Each Predictor and Event for All Patients and by Race


Disclosure: M. Petri, Astrazeneca, 2, 5, Exagen, 2, 5, GlaxoSmithKline (GSK), 2, 5, Eli Lilly and Company, 2, 5, AbbVie Inc., 5, Aleon Pharma International, Inc, 5, Amgen, 5, Annenberg Center for Health Sciences,, 5, Blackrock Pharma, 5, Bristol Myers Squibb, 5, Decision Resources, 5, Glenmark Pharmaceuticals, 5, INOVA, 5, IQVIA, 5, Janssen Pharmaceutical, 5, Merck EMD Serono, 5, Novartis, 5, Sanofi Japan, 5, Thermofisher, 5, UCB, 5; J. Li, None; D. Goldman, None.

To cite this abstract in AMA style:

Petri M, Li J, Goldman D. Early Peak of Cardiovascular Events Occurs Equally in Caucasians and African-American SLE but Is Attributed to Different Risk Factors [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/early-peak-of-cardiovascular-events-occurs-equally-in-caucasians-and-african-american-sle-but-is-attributed-to-different-risk-factors/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/early-peak-of-cardiovascular-events-occurs-equally-in-caucasians-and-african-american-sle-but-is-attributed-to-different-risk-factors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology